Axon - Logo

Genetic Counseling

Professional psychologist conducting a consultation

What do our genes have to do with mental health?

Genes play a significant role in mental health. Here are a few key points regarding the relationship between genes and mental health:

  • Genetic predisposition: Certain mental health disorders have a hereditary component, meaning they tend to run in families. Having a close relative with a mental health condition can increase an individual’s likelihood of developing the same or a related disorder. This suggests a genetic predisposition to these conditions.
  • Medication responses: Genes can significantly influence an individual’s response to medications, including those used in mental health treatment. Here are some key ways in which genes impact medication response:
    • Pharmacokinetics: Genes can affect the way medications are absorbed, distributed, metabolized, and eliminated by the body. Enzymes involved in drug metabolism, such as cytochrome P450 enzymes, are encoded by specific genes. Variations in these genes can lead to differences in how quickly or effectively medications are processed in the body. This can result in variations in drug levels and how long the medication remains active, impacting its efficacy and potential side effects.
    • Pharmacodynamics: Genes can influence how medications interact with their target receptors or molecular targets in the body. Variations in genes encoding these targets can affect the drug’s ability to bind and exert its therapeutic effects. For example, certain genetic variations can impact the effectiveness of antidepressants by altering the function or expression of neurotransmitter receptors.
    • Treatment response and efficacy: Genetic variations can contribute to differences in treatment response and medication efficacy among individuals. Some individuals may have genetic factors that make them more or less responsive to certain medications. For instance, genetic variations in the serotonin transporter gene can influence an individual’s response to selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medications.
    • Side effects and adverse reactions: Genetic factors can also influence an individual’s susceptibility to medication side effects or adverse reactions. Some people may carry genetic variations that affect the metabolism of certain medications, leading to an increased risk of side effects. For example, a genetic variation in the HLA-B gene is associated with a higher risk of a severe and potentially life-threatening skin reaction called Stevens-Johnson syndrome in response to specific medications.

Do genes cause mental health disorders?

Genes do not solely cause mental health disorders. Mental health disorders are complex conditions that arise from a combination of genetic, environmental, and lifestyle factors. While genetic variations can contribute to an individual’s susceptibility to certain mental health disorders, they are not the sole determining factor.  Here are some key points to consider:

  • Multifactorial nature: Mental health disorders are generally considered to be multifactorial, meaning they result from a combination of genetic, environmental, and lifestyle influences. Genetic variations can increase the risk of developing a disorder but are typically not sufficient on their own to cause the disorder to manifest.
  • Genetic predisposition: Some mental health disorders have a hereditary component, suggesting that certain genetic variations can contribute to an increased risk of developing the disorder. However, having a genetic predisposition does not guarantee that an individual will develop the disorder. Environmental factors and life experiences also play critical roles in determining whether the genetic risk will be expressed.
  • Gene-environment interaction: Genes interact with environmental factors to shape the risk of developing mental health disorders. Environmental factors such as stress, trauma, abuse, socioeconomic circumstances, and access to support and resources can significantly impact the development and course of mental health conditions, even in individuals with a genetic predisposition.
  • Complex genetics: Mental health disorders are generally polygenic, meaning they involve the interaction of multiple genes. Rather than being caused by a single gene, mental health disorders are influenced by the combined effects of many genetic variations, each with a relatively small impact. Identifying specific genes associated with mental health disorders is a complex task, and the contribution of individual genes to the development of these disorders is often modest.
  • Epigenetics: Epigenetic factors can influence gene expression without altering the underlying DNA sequence. Environmental factors, such as stress or early-life experiences, can impact the epigenetic regulation of genes related to mental health. These changes can potentially increase the risk of developing mental health disorders but are not solely determined by genes.

In summary, genes contribute to the risk of developing mental health disorders, but they are not the sole cause. Mental health disorders are the result of complex interactions between genetic, environmental, and lifestyle factors. Understanding these interactions is essential for a comprehensive understanding of mental health and the development of effective prevention and treatment strategies.

What is Pharmacogenomic testing?

Pharmacogenomic testing, also known as pharmacogenetic testing or genetic testing for drug response, is a type of genetic analysis that examines an individual’s genetic variations to predict their response to medications. It involves analyzing specific genes or genetic markers that are known to influence drug metabolism, drug targets, or treatment response.  The process of pharmacogenomic testing typically involves the following steps:

  • Sample collection: A sample is collected from the individual, usually through a simple blood draw or a cheek swab. The sample contains DNA, which carries the genetic information.
  • Genetic analysis: The DNA sample is then analyzed in a laboratory using various techniques, such as polymerase chain reaction (PCR), microarray analysis, or next-generation sequencing. These methods allow for the detection and characterization of specific genetic variations.
  • Interpretation of results: The genetic data obtained from the analysis is interpreted in the context of known associations between genetic variations and medication response. The results provide information about how an individual’s genetic makeup may influence their ability to metabolize medications, their potential response to specific drugs, and their risk of experiencing adverse reactions or side effects.
  • Clinical application: The interpreted results are used by healthcare providers to guide treatment decisions. They can help determine the most appropriate medication choice, dosage adjustments, or the selection of alternative therapies based on the individual’s genetic profile. Pharmacogenomic testing results can also assist in identifying medications that may be less effective or have a higher risk of adverse effects for a particular individual.

Pharmacogenomic testing is increasingly being integrated into clinical practice. It aims to optimize medication selection and dosing, enhance treatment outcomes, and reduce the risk of adverse drug reactions. However, it’s important to note that pharmacogenomic testing is not applicable to all medications and conditions, and its utility may vary depending on the specific drug-gene interactions and the availability of evidence-based guidelines. The decision to undergo pharmacogenomic testing should be made in consultation with a healthcare professional who can assess its potential benefits and limitations for an individual’s specific situation.

Will pharmacogenomic testing tell me what medications will help me?

Unfortunately, mental health disorders are extremely complex and there are no ways to exactly predict an individual’s response to medications.  It is important to note that pharmacogenomic testing is not a definitive predictor of individual medication response. It provides guidance based on the known associations between genetic variations and drug responses observed in scientific research and clinical studies. The field of pharmacogenomics is continually evolving as more data and evidence become available.

The results of pharmacogenomic testing should be interpreted in conjunction with other factors, such as your medical history, symptoms, and ongoing monitoring, in collaboration with a healthcare professional. The ultimate decision about medication selection and dosing should be made based on a comprehensive evaluation of all relevant factors and with consideration of the individual’s unique circumstances.

Pharmacogenomic testing can be particularly useful in certain scenarios, such as when there are multiple medication options available, when previous medications have been ineffective or caused adverse effects, or when there is a known genetic risk factor for medication-related complications. It can help inform treatment decisions, enhance medication selection, and potentially improve treatment outcomes by guiding healthcare providers in choosing medications that are more likely to be effective and well-tolerated for a particular individual.

It’s important to work closely with a qualified healthcare professional who has expertise in pharmacogenomics to interpret the test results and guide you in making informed decisions about your treatment plan.